[4'-epidoxorubicin].
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D015251:Epirubicin; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy
D000903:Antibiotics, Antineoplastic; D015251:Epirubicin; D004317:Doxorubicin
4'-epi-doxorubicin.